Susquehanna International Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8M | Sell |
439,392
-932,234
| -68% | -$33.6M | ﹤0.01% | 509 |
|
|
2025
Q1 | $42.7M | Sell |
1,371,626
-698,916
| -34% | -$21.8M | 0.01% | 178 |
|
|
2024
Q4 | $52.8M | Buy |
2,070,542
+417,680
| +25% | +$10.7M | 0.01% | 182 |
|
|
2024
Q3 | $46.8M | Buy |
1,652,862
+157,504
| +11% | +$4.46M | 0.01% | 181 |
|
|
2024
Q2 | $39.4M | Buy |
1,495,358
+1,063,108
| +246% | +$28M | 0.01% | 201 |
|
|
2024
Q1 | $13.1M | Buy |
432,250
+1,617
| +0.4% | +$49.1K | ﹤0.01% | 522 |
|
|
2023
Q4 | $12.1M | Sell |
430,633
-110,814
| -20% | -$3.11M | ﹤0.01% | 604 |
|
|
2023
Q3 | $14.7M | Buy |
541,447
+156,708
| +41% | +$4.25M | ﹤0.01% | 540 |
|
|
2023
Q2 | $11.8M | Buy |
384,739
+139,703
| +57% | +$4.29M | ﹤0.01% | 625 |
|
|
2023
Q1 | $8.83M | Buy |
245,036
+70,106
| +40% | +$2.53M | ﹤0.01% | 800 |
|
|
2022
Q4 | $6.91M | Buy |
+174,930
| New | +$6.91M | ﹤0.01% | 781 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6781 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6550 |
|
|
2022
Q1 | – | Sell |
-6,996
| Closed | -$279K | – | 6408 |
|
|
2021
Q4 | $279K | Buy |
+6,996
| New | +$279K | ﹤0.01% | 4572 |
|
|
2021
Q3 | – | Sell |
-32,027
| Closed | -$1.31M | – | 5963 |
|
|
2021
Q2 | $1.31M | Sell |
32,027
-198,593
| -86% | -$8.14M | ﹤0.01% | 2622 |
|
|
2021
Q1 | $10.1M | Buy |
230,620
+220,467
| +2,171% | +$9.62M | ﹤0.01% | 775 |
|
|
2020
Q4 | $508K | Sell |
10,153
-73,955
| -88% | -$3.7M | ﹤0.01% | 3390 |
|
|
2020
Q3 | $3.54M | Buy |
84,108
+46,895
| +126% | +$1.97M | ﹤0.01% | 1021 |
|
|
2020
Q2 | $1.81M | Buy |
+37,213
| New | +$1.81M | ﹤0.01% | 1536 |
|